NCT05641935
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
Clinical trial condition
Recurrent Renal Cell Carcinoma
Explore clinical trials studying Recurrent Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
30 public trials
1 recruiting study
Recurrent Renal Cell Carcinoma trial results
Not Yet Recruiting
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
NCT07218692
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +23 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
NCT02318771
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +39 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT01767636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma of the Collecting Ducts of Bellini, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT01061411
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Academ Zienkenhuis Bij De University Amsterdam, Netherlands
- VU University Medical Center Amsterdam, Netherlands
NCT02035358
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- John Hopkins University Baltimore, Maryland, United States
- Univeristy of Utah Salt Lake City, Utah, United States
NCT00121251
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
- Mount Sinai Hospital New York, United States
- Weill Medical College of Cornell University New York, United States
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
Completed
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignant Neoplasm, +73 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States